BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 16763549)

  • 1. Glycosaminoglycan modification of neuropilin-1 modulates VEGFR2 signaling.
    Shintani Y; Takashima S; Asano Y; Kato H; Liao Y; Yamazaki S; Tsukamoto O; Seguchi O; Yamamoto H; Fukushima T; Sugahara K; Kitakaze M; Hori M
    EMBO J; 2006 Jul; 25(13):3045-55. PubMed ID: 16763549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor (VEGF)-A165b is a weak in vitro agonist for VEGF receptor-2 due to lack of coreceptor binding and deficient regulation of kinase activity.
    Kawamura H; Li X; Harper SJ; Bates DO; Claesson-Welsh L
    Cancer Res; 2008 Jun; 68(12):4683-92. PubMed ID: 18559514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VEGF-A165 induces human aortic smooth muscle cell migration by activating neuropilin-1-VEGFR1-PI3K axis.
    Banerjee S; Mehta S; Haque I; Sengupta K; Dhar K; Kambhampati S; Van Veldhuizen PJ; Banerjee SK
    Biochemistry; 2008 Mar; 47(11):3345-51. PubMed ID: 18284215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells.
    Hsieh SH; Ying NW; Wu MH; Chiang WF; Hsu CL; Wong TY; Jin YT; Hong TM; Chen YL
    Oncogene; 2008 Jun; 27(26):3746-53. PubMed ID: 18223683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting neuropilin 1 as an antitumor strategy in lung cancer.
    Hong TM; Chen YL; Wu YY; Yuan A; Chao YC; Chung YC; Wu MH; Yang SC; Pan SH; Shih JY; Chan WK; Yang PC
    Clin Cancer Res; 2007 Aug; 13(16):4759-68. PubMed ID: 17699853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra- and extracellular signaling by endothelial neuregulin-1.
    Iivanainen E; Paatero I; Heikkinen SM; Junttila TT; Cao R; Klint P; Jaakkola PM; Cao Y; Elenius K
    Exp Cell Res; 2007 Aug; 313(13):2896-909. PubMed ID: 17499242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropilin-1 regulates vascular endothelial growth factor-mediated endothelial permeability.
    Becker PM; Waltenberger J; Yachechko R; Mirzapoiazova T; Sham JS; Lee CG; Elias JA; Verin AD
    Circ Res; 2005 Jun; 96(12):1257-65. PubMed ID: 15920019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparan sulfate proteoglycans mediate the angiogenic activity of the vascular endothelial growth factor receptor-2 agonist gremlin.
    Chiodelli P; Mitola S; Ravelli C; Oreste P; Rusnati M; Presta M
    Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):e116-27. PubMed ID: 21921258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor receptor-1 regulates postnatal angiogenesis through inhibition of the excessive activation of Akt.
    Nishi J; Minamino T; Miyauchi H; Nojima A; Tateno K; Okada S; Orimo M; Moriya J; Fong GH; Sunagawa K; Shibuya M; Komuro I
    Circ Res; 2008 Aug; 103(3):261-8. PubMed ID: 18583712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropilin-1 binds to VEGF121 and regulates endothelial cell migration and sprouting.
    Pan Q; Chathery Y; Wu Y; Rathore N; Tong RK; Peale F; Bagri A; Tessier-Lavigne M; Koch AW; Watts RJ
    J Biol Chem; 2007 Aug; 282(33):24049-56. PubMed ID: 17575273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel human-specific soluble vascular endothelial growth factor receptor 1: cell-type-specific splicing and implications to vascular endothelial growth factor homeostasis and preeclampsia.
    Sela S; Itin A; Natanson-Yaron S; Greenfield C; Goldman-Wohl D; Yagel S; Keshet E
    Circ Res; 2008 Jun; 102(12):1566-74. PubMed ID: 18515749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth.
    Pan Q; Chanthery Y; Liang WC; Stawicki S; Mak J; Rathore N; Tong RK; Kowalski J; Yee SF; Pacheco G; Ross S; Cheng Z; Le Couter J; Plowman G; Peale F; Koch AW; Wu Y; Bagri A; Tessier-Lavigne M; Watts RJ
    Cancer Cell; 2007 Jan; 11(1):53-67. PubMed ID: 17222790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NRP1 presented in trans to the endothelium arrests VEGFR2 endocytosis, preventing angiogenic signaling and tumor initiation.
    Koch S; van Meeteren LA; Morin E; Testini C; Weström S; Björkelund H; Le Jan S; Adler J; Berger P; Claesson-Welsh L
    Dev Cell; 2014 Mar; 28(6):633-46. PubMed ID: 24656741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-amniotic infection upregulates decidual cell vascular endothelial growth factor (VEGF) and neuropilin-1 and -2 expression: implications for infection-related preterm birth.
    Snegovskikh VV; Schatz F; Arcuri F; Toti P; Kayisli UA; Murk W; Guoyang Luo ; Lockwood CJ; Norwitz ER
    Reprod Sci; 2009 Aug; 16(8):767-80. PubMed ID: 19474288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial cell response to lactate: implication of PAR modification of VEGF.
    Kumar VB; Viji RI; Kiran MS; Sudhakaran PR
    J Cell Physiol; 2007 May; 211(2):477-85. PubMed ID: 17167776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropilin-VEGF signaling pathway acts as a key modulator of vascular, lymphatic, and inflammatory cell responses of the bladder to intravesical BCG treatment.
    Saban MR; Sferra TJ; Davis CA; Simpson C; Allen A; Maier J; Fowler B; Knowlton N; Birder L; Wu XR; Saban R
    Am J Physiol Renal Physiol; 2010 Dec; 299(6):F1245-56. PubMed ID: 20861073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute resistance exercise increases skeletal muscle angiogenic growth factor expression.
    Gavin TP; Drew JL; Kubik CJ; Pofahl WE; Hickner RC
    Acta Physiol (Oxf); 2007 Oct; 191(2):139-46. PubMed ID: 17565567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of VEGF-mediated signaling in primary human cells reveals a paracrine action for VEGF in osteoblast-mediated crosstalk to endothelial cells.
    Clarkin CE; Emery RJ; Pitsillides AA; Wheeler-Jones CP
    J Cell Physiol; 2008 Feb; 214(2):537-44. PubMed ID: 17685428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose is a key regulator of VEGFR2/KDR in human epithelial ovarian carcinoma cells.
    Adham SA; Coomber BL
    Biochem Biophys Res Commun; 2009 Dec; 390(1):130-5. PubMed ID: 19782046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.
    Narita K; Staub J; Chien J; Meyer K; Bauer M; Friedl A; Ramakrishnan S; Shridhar V
    Cancer Res; 2006 Jun; 66(12):6025-32. PubMed ID: 16778174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.